Business Wire

OR-OPEN19-FOUNDATION

Share
Open19 Foundation Joins Kinetic Edge Alliance

The Open19 Foundation, an organization established to create a community for a new generation of open data centers and edge solutions, today announced its membership within the Kinetic Edge™ Alliance (KEA) as a technology partner. The future of computing is at the edge, and this partnership will accelerate deployment of Open19 infrastructure into edge locations.

“The Kinetic Edge Alliance is the de-facto alliance that is creating order and a blueprint to build the edge technology specifically for edge cloud applications,” said Yuval Bachar, Open19 Foundation President. “The Open19 Foundation will join the Kinetic Edge Alliance to add the hardware buildout building block to the alliance with the Open19 platform. The Open19 platform is designed for the edge and optimized for the solution as defined by the Kinetic Edge alliance. It will enable a standard but flexible solution for building the Edge platforms of the present and the future.”

Founded by Open19 Foundation member company Vapor IO , the Kinetic Edge Alliance is an industry working group dedicated to making edge computing easy and connecting stakeholders with end users and customers. Other members of the group include Packet, New Continuum Data Centers, and Seagate. Learn more about the Alliance here .

“The Open19 standard makes it fast and economical to deploy equipment in edge environments,” said Matt Trifiro, CMO of Vapor IO. “By offering a chassis design that slides in and out of a rack, installing or swapping out data center equipment becomes almost as easy as opening and closing a desk drawer. This makes it possible for technicians to deploy or repair edge equipment in minutes instead of hours or days.”

Twelve partner companies launched the Kinetic Edge Alliance in February 2019 for the purpose of driving broad adoption of compute, storage, access and interconnection at the edge of the cellular network, simplifying edge computing for the masses. The Alliance is actively rolling out equipment and services across the top 30 major metropolitan US markets, beginning with the first six markets in 2019. The Alliance seeks to deploy, in lockstep, all of the key hardware and software infrastructure components that will enable commercial-grade edge computing at scale. There are now nearly 40 partner companies in the Alliance.

About the Open19 Foundation

The Open19 Foundation was established in 2017 by founding members Flex, GE Digital, Hewlett Packard Enterprise, LinkedIn, Packet, and Vapor IO to create a community that will enable a common optimized data center and edge solutions. It has since grown to 26 members from all parts of the edge ecosystem – from component and system suppliers and integrators, to data center operators. For more information, visit the Foundation’s website at www.open19.org .

Contact:

Open19 Foundation Rachael Watson, PR manager rwatson@nereus-worldwide.com (971) 706-1312

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Sodali & Co Announces Executive Leadership Appointments7.1.2026 17:00:00 CET | Press release

Accelerates Firm Strategy to Deliver Global Integrated Stakeholder Solutions Sodali & Co (the ‘firm’ or ‘Sodali’), the leading global capital markets-centric stakeholder advisory firm, is pleased to announce four appointments to its Executive Leadership Team (ELT) under Chief Executive Officer Andrew Benett. These newly created senior roles will strengthen Sodali’s ability to respond to clients’ evolving needs with an integrated suite of shareholder, sustainability, and strategic communications advisory services delivered on a global scale. The appointments are as follows: Brett Clegg has been promoted to Chief Commercial Officer. Brett was previously Chairman of Sodali’s APAC region, based in the firm’s Sydney office. He specializes in advising clients on strategic communications, issues management, and capital markets transactions. Prior to Sodali, Brett spent over two decades in senior executive and editorial roles at some of Australia’s leading news brands, including The Australian

1NCE Continues Growth and Expands Its Software, AI and Services Offering7.1.2026 14:15:00 CET | Press release

In 2025 1NCE added another 10 million endpoints to its foundational IoT platform; now manages 40+ million intelligent products for 30,000 customers in 17 industries. Introduces new software, 1NCE Insights, the AI + IoT fusion of intelligence from its network that gives analytics and benchmark data on how customers can better setup, manage and optimize their device estates. 1NCE, a company offering a plug-and-play platform for creating and managing the world’s best IoT products, reports another strong growth year, adding another 10 million endpoints. The company now manages 40+ million intelligent products for 30,000+ customers across 17 industries. 1NCE’s software and connectivity platform has become a new industry standard, delivering hassle-free IoT in 170+ countries and regions. The company has a unique vantage point in the IoT ecosystem, with four billion data records per day collected through 250+ streams on the world’s largest IoT network in the cloud. The company launched a new

Prudentia Sciences Announces Series A Led by McKesson Ventures, Accelerating Due Diligence for Life Sciences Dealmaking7.1.2026 14:00:00 CET | Press release

Prudentia Sciences, a pioneer in AI-native due diligence for life sciences dealmaking, today announced that it has secured $20 million in Series A financing. The round was led by McKesson Ventures with participation from SignalFire. Existing investors include Iaso Ventures, Virtue and GV. This brings the company’s total funding to $27 million, following a $7 million seed round in 2024. Prudentia Sciences provides an AI-native platform that enables pharma companies, biotechs, and financial institutions to evaluate breakthrough medicines with unprecedented speed and rigor. By synthesizing complex clinical signals into actionable insights, Prudentia accelerates deal throughput and provides strategic leverage for acquisition, licensing, or investment decisions made by business development, investment, and diligence teams. The company’s human-in-the-loop approach orchestrates seamless collaboration between buyers, sellers, and intermediaries. This ensures a secure, compliant infrastructure

Compass Pathways Announces FDA Acceptance of IND Application for PTSD and Hosts Webinar on PTSD and TRD7.1.2026 12:30:00 CET | Press release

FDA Accepts Investigational New Drug (IND) Application for COMP360 for the treatment of post-traumatic stress disorder (PTSD), enabling initiation of late-stage trialCompass continues to advance commercial preparations to be launch-ready by the end of the year for COMP360 for treatment-resistant depression (TRD)Management will host webinar with KOL and industry leaders to discuss PTSD clinical trial and commercial preparations for TRD from 10:00-11:30 am ET on January 7th Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, today announced that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application for COMP360, enabling the initiation of a late-stage clinical trial in patients with PTSD. Compass management, along with KOL and industry leaders, will host a webinar today to discuss the company’s clinical trial plans for PTSD, as well as commercial preparations f

Stallergenes Greer Expands Venom Immunotherapy Production Capacity With Acquisition of Entomon s.r.l.7.1.2026 11:07:00 CET | Press release

Stallergenes Greer, a global leader in allergy therapeutics, today announced that it has entered into an agreement to acquire Entomon s.r.l., an Italian company specialising in the production of certified stinging-insect venom extracts, notably of the Hymenoptera order, used for the manufacture of diagnostic preparations and Venom Immunotherapy (VIT). The transaction is expected to close by the end of January. Entomon, currently recognised as the only company in Europe capable of extracting pure venom from Hymenoptera insects, produces pharmaceutical-grade insect venom using proprietary techniques (Entomon Capillary Extracted Venom®) for medical use. Through this acquisition, Stallergenes Greer bolsters its venom manufacturing capabilities and supply of raw materials for life-saving VIT treatments, whilst safeguarding patient care continuity. Hymenoptera venom allergy is the most common trigger of severe anaphylaxis in adults1. According to the EAACI guidelines on venom immunotherapy,

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye